Watson Announces a Nationwide Voluntary Recall of Propafenone HCL Tablets Due
to Oversized Tablets
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical
company, announced today that one lot of Propafenone HCL 225 mg Tablets sold in 100 count bottles in the United
States is being voluntarily recalled to the consumer level as a precautionary measure. The lot is being recalled
because some tablets may contain slightly higher levels of the active ingredient than specified. The recalled tablets
were manufactured by Watson Laboratories, Inc. The affected lot of Propafenone HCL tablets was shipped to
customers between October 15, 2008 and November 26, 2008.
Read
more...